Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2023

Open Access 01-12-2023 | Case Report

Case report: Takotsubo syndrome following percutaneous coronary intervention

Authors: Rui Lu, Mingjun Lu, Shangfei He, Jing Lu, Yi Liao, Tongtao Cui, Min Wang

Published in: Journal of Cardiothoracic Surgery | Issue 1/2023

Login to get access

Abstract

Background

Takotsubo syndrome (TTS), which is frequently secondary to severe emotional (fear, anxiety, etc.) or physical stress, is an acute reversible heart failure syndrome characterized by temporary left ventricular regional systolic dysfunction. Nevertheless, TTS after percutaneous coronary intervention (PCI) is rare, and its clinical characteristics are easily confused with complications after PCI.

Case presentation

This article reports a case of TTS induced by psychological and physical pressure after successful PCI in our institution. The patient had symptoms comparable to complications after PCI, including V1-V5 ST segment elevation and T wave changes of electrocardiogram (ECG) and troponin elevation. Coronary angiogram, left ventricle opacification (LVO), and cardiac magnetic resonance (CMR) were performed to exclude postoperative complications. Diagnosis of TTS was eventually achieved.

Conclusion

We cannot dismiss the risk of TTS in patients who have unexplained V1-V5 ST segment elevation and T wave changes of ECG and troponin elevation following successful PCI. Meanwhile, medical personnel should provide mental, cultural, and emotional services to patients in addition to essential diagnostic and treatment technical services during the perioperative period.
Literature
1.
go back to reference Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, Diagnostic Criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–46.CrossRefPubMedPubMedCentral Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, Diagnostic Criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–46.CrossRefPubMedPubMedCentral
2.
go back to reference Topf A, Mirna M, Paar V, et al. The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome [published correction appears in Clin Res Cardiol. 2021]. Clin Res Cardiol. 2022;111(2):197–206.CrossRefPubMed Topf A, Mirna M, Paar V, et al. The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome [published correction appears in Clin Res Cardiol. 2021]. Clin Res Cardiol. 2022;111(2):197–206.CrossRefPubMed
3.
4.
go back to reference Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo Syndrome Circulation. 2017;135(24):2426–41.PubMed Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo Syndrome Circulation. 2017;135(24):2426–41.PubMed
5.
go back to reference Akhtar MM, Cammann VL, Templin C, et al. Takotsubo syndrome: getting closer to its causes. Cardiovasc Res. 2023;119(7):1480–94.CrossRefPubMed Akhtar MM, Cammann VL, Templin C, et al. Takotsubo syndrome: getting closer to its causes. Cardiovasc Res. 2023;119(7):1480–94.CrossRefPubMed
6.
go back to reference Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706.CrossRefPubMedPubMedCentral Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706.CrossRefPubMedPubMedCentral
8.
go back to reference Coronary artery perforation: How to treat it?[J].Cor Et Vasa., 2015, 57(5):e334-e340. Coronary artery perforation: How to treat it?[J].Cor Et Vasa., 2015, 57(5):e334-e340.
9.
go back to reference Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.CrossRefPubMed Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–38.CrossRefPubMed
10.
go back to reference Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955–71.CrossRefPubMed Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955–71.CrossRefPubMed
11.
go back to reference Montone RA, La Vecchia G, Del Buono MG, et al. Takotsubo Syndrome in Intensive Cardiac Care Unit: challenges in diagnosis and management. Curr Probl Cardiol. 2022;47(11):101084.CrossRefPubMed Montone RA, La Vecchia G, Del Buono MG, et al. Takotsubo Syndrome in Intensive Cardiac Care Unit: challenges in diagnosis and management. Curr Probl Cardiol. 2022;47(11):101084.CrossRefPubMed
12.
go back to reference Ledwidge M, Dodd JD, Ryan F, et al. Effect of Sacubitril/Valsartan vs Valsartan onLeft Atrial volume in patients with Pre-heart failure with preserved ejection fraction. ThePARABLE Randomized Clinical Trial [J].JAMA Cardiol; 2023. p. e230065. Ledwidge M, Dodd JD, Ryan F, et al. Effect of Sacubitril/Valsartan vs Valsartan onLeft Atrial volume in patients with Pre-heart failure with preserved ejection fraction. ThePARABLE Randomized Clinical Trial [J].JAMA Cardiol; 2023. p. e230065.
13.
go back to reference Mc Causland FR, Lefkowitz MP, Claggett B et al. Angiotensin-neprilysin inhibitionand renal outcomes in Heart Failure with preserved ejection Fraction[JJ. Circulation, 2020142(13):1236–45. Mc Causland FR, Lefkowitz MP, Claggett B et al. Angiotensin-neprilysin inhibitionand renal outcomes in Heart Failure with preserved ejection Fraction[JJ. Circulation, 2020142(13):1236–45.
14.
go back to reference Meng LP, Zhang P. Takotsubo cardiomyopathy misdiagnosed as acute Myocardial Infarction under the chest Pain Center model: a case report. World J Clin Cases. 2022;10(8):2616–21.CrossRefPubMedPubMedCentral Meng LP, Zhang P. Takotsubo cardiomyopathy misdiagnosed as acute Myocardial Infarction under the chest Pain Center model: a case report. World J Clin Cases. 2022;10(8):2616–21.CrossRefPubMedPubMedCentral
15.
go back to reference Gassan Moady G, Rubinstein L, Mobarki S, Atar. Takotsubo Syndrome in the Emergency Room — Diagnostic challenges and suggested Algorithm. Rev Cardiovasc Med. 2022;23(4):131.CrossRef Gassan Moady G, Rubinstein L, Mobarki S, Atar. Takotsubo Syndrome in the Emergency Room — Diagnostic challenges and suggested Algorithm. Rev Cardiovasc Med. 2022;23(4):131.CrossRef
16.
go back to reference Stiermaier T, Walliser A, El-Battrawy I, et al. Happy heart syndrome: frequency, characteristics, and outcome of Takotsubo Syndrome triggered by positive life events. JACC Heart Fail. 2022;10(7):459–66.CrossRefPubMed Stiermaier T, Walliser A, El-Battrawy I, et al. Happy heart syndrome: frequency, characteristics, and outcome of Takotsubo Syndrome triggered by positive life events. JACC Heart Fail. 2022;10(7):459–66.CrossRefPubMed
Metadata
Title
Case report: Takotsubo syndrome following percutaneous coronary intervention
Authors
Rui Lu
Mingjun Lu
Shangfei He
Jing Lu
Yi Liao
Tongtao Cui
Min Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2023
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-023-02412-0

Other articles of this Issue 1/2023

Journal of Cardiothoracic Surgery 1/2023 Go to the issue